Cargando…

Health outcomes, education, healthcare delivery and quality – 3057. Randomized, double blind comparative study to assess safety, efficacy with mometasone & formoterol versus fluticasone & formoterol dry powder inhaler (DPI) in the treatment of mild to moderate persistent asthma

Detalles Bibliográficos
Autor principal: Chandra, Sathish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643242/
http://dx.doi.org/10.1186/1939-4551-6-S1-P225
_version_ 1782268285337731072
author Chandra, Sathish
author_facet Chandra, Sathish
author_sort Chandra, Sathish
collection PubMed
description
format Online
Article
Text
id pubmed-3643242
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-36432422013-05-08 Health outcomes, education, healthcare delivery and quality – 3057. Randomized, double blind comparative study to assess safety, efficacy with mometasone & formoterol versus fluticasone & formoterol dry powder inhaler (DPI) in the treatment of mild to moderate persistent asthma Chandra, Sathish World Allergy Organ J Meeting Abstract World Allergy Organization 2013-04-23 /pmc/articles/PMC3643242/ http://dx.doi.org/10.1186/1939-4551-6-S1-P225 Text en Copyright ©2013 Chandra; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Chandra, Sathish
Health outcomes, education, healthcare delivery and quality – 3057. Randomized, double blind comparative study to assess safety, efficacy with mometasone & formoterol versus fluticasone & formoterol dry powder inhaler (DPI) in the treatment of mild to moderate persistent asthma
title Health outcomes, education, healthcare delivery and quality – 3057. Randomized, double blind comparative study to assess safety, efficacy with mometasone & formoterol versus fluticasone & formoterol dry powder inhaler (DPI) in the treatment of mild to moderate persistent asthma
title_full Health outcomes, education, healthcare delivery and quality – 3057. Randomized, double blind comparative study to assess safety, efficacy with mometasone & formoterol versus fluticasone & formoterol dry powder inhaler (DPI) in the treatment of mild to moderate persistent asthma
title_fullStr Health outcomes, education, healthcare delivery and quality – 3057. Randomized, double blind comparative study to assess safety, efficacy with mometasone & formoterol versus fluticasone & formoterol dry powder inhaler (DPI) in the treatment of mild to moderate persistent asthma
title_full_unstemmed Health outcomes, education, healthcare delivery and quality – 3057. Randomized, double blind comparative study to assess safety, efficacy with mometasone & formoterol versus fluticasone & formoterol dry powder inhaler (DPI) in the treatment of mild to moderate persistent asthma
title_short Health outcomes, education, healthcare delivery and quality – 3057. Randomized, double blind comparative study to assess safety, efficacy with mometasone & formoterol versus fluticasone & formoterol dry powder inhaler (DPI) in the treatment of mild to moderate persistent asthma
title_sort health outcomes, education, healthcare delivery and quality – 3057. randomized, double blind comparative study to assess safety, efficacy with mometasone & formoterol versus fluticasone & formoterol dry powder inhaler (dpi) in the treatment of mild to moderate persistent asthma
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643242/
http://dx.doi.org/10.1186/1939-4551-6-S1-P225
work_keys_str_mv AT chandrasathish healthoutcomeseducationhealthcaredeliveryandquality3057randomizeddoubleblindcomparativestudytoassesssafetyefficacywithmometasoneformoterolversusfluticasoneformoteroldrypowderinhalerdpiinthetreatmentofmildtomoderatepersistentasthma